Adenovirus 40 and 41 Antibodies Associated With Protection From Infection in a Bangladeshi Birth Cohort
The Journal of Infectious Diseases · 2026
DOI: 10.1093/infdis/jiaf558 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Jennifer Hendrick und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Antibodies, Viral, Adenovirus Infections, Human, Adenoviruses, Human, Gastroenteritis. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCATS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Background
Adenovirus (AdV) 40/41 is a major cause of pediatric acute gastroenteritis (AGE), leading to significant morbidity and mortality worldwide. As little is known about clinical correlates of protection, we analyzed AdV-specific antibody reactivities using a multi-AdV protein microarray and serum from a Bangladeshi birth cohort surveilled for diarrhea during the first 2 years of life.
Methods
Arrays contained a comprehensive set of proteins from AdV 40 and 41, in addition to respiratory AdVs 4, 5, and 26. Children were split into four groups according to AdV 40/41 infection occurrence during year 1 (Y1) and year 2 (Y2) of life. One-year array antibody reactivity levels were analyzed from 119 children using principal component analysis (PCA). Top antibody reactivities were evaluated for associations with AdV 40/41 disease severity and protection in Year 2 using logistic regression.
Results
Eight principal components (PCs) were identified from PCA. Top targets contributing to the leading PCs included external AdV 40/41 antigens that function in host cell entry, particularly penton base (PB) proteins. AdV 41 PB antibody reactivity at Year 1 is significantly associated with reduced risk of AdV 40/41 infection in Year 2 (OR = 0.36, 95% CI: 0.16–0.80, P = .013, adjusted P = .003). Additionally, those with mild to moderate infections in Year 2 had higher reactivities to AdV 40 and 41 PB compared to severe infections (P = .008 and .032, respectively).
Conclusions
Higher antibody reactivity to AdV PB was associated with improved Year 2 AdV 40/41 outcomes, elevating it as a promising vaccine or monoclonal antibody target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.
- Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
- Antigen Discovery Incorporated (ADI), Irvine California, USA.
- Center for Virus Research, University of California, Irvine, California, USA.
- Department of Developmental and Cell Biology, University of California, Irvine, California, USA.
- Department of Microbiology, Immunology and Cancer Biology, University of Virginia Health System, Charlottesville, Virginia, USA.
ORCID-Profile: Jennifer Hendrick, Jennie Z Ma, Jozelyn V Pablo, Amit Oberai, Joseph J Campo, David Camerini
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- NIH HHS
- National Institutes of Allergy and Infectious Diseases
- National Center for Advancing Translational Sciences
- National Institutes of Health
Zitieren
APA
Hendrick, J., Ma, J. Z., Huynh, V., Pablo, J. V., Teng, A. A., Oberai, A., Campo, J. J., Camerini, D., & Petri, W. A. (2026). Adenovirus 40 and 41 Antibodies Associated With Protection From Infection in a Bangladeshi Birth Cohort. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf558
Vancouver
Hendrick J, Ma JZ, Huynh V, Pablo JV, Teng AA, Oberai A, et al. Adenovirus 40 and 41 Antibodies Associated With Protection From Infection in a Bangladeshi Birth Cohort. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiaf558
BibTeX
@article{Hendrick2026,
author = {Hendrick, Jennifer and Ma, Jennie Z and Huynh, Vu and Pablo, Jozelyn V and Teng, Andy A and Oberai, Amit and Campo, Joseph J and Camerini, David and Petri, William A},
title = {Adenovirus 40 and 41 Antibodies Associated With Protection From Infection in a Bangladeshi Birth Cohort},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiaf558}
}
EUVIMED